The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...
People with chronic liver disease have dramatic changes to the types and functions of bacteria in the gut and mouth, a new study has revealed.
Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback